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ABSTRACT

Probe-Level Statistical Models for Differential Expression of Genes in Bovine NT
Studies

by
Jason L. Bell, Master of Science
Utah State University, 2009

Major Professor: Dr. John R. Stevens
Department: Mathematics and Statistics
A brief introduction of microarray technology and its uses is given. This technology is commonly used in agricultural research, including research in nuclear transfer, which motivated this study. There are 3 classes of statistical models compared:
probeset-level, weighted probeset-level and probe-level.
Different statistical

mod els are compared on 3 spike-in experiments to assess

the relative performance in identifying differentially exp ressed genes . A novel nested
factorial model was found to outperform all other models compared in this study in
one spike-in experiment, and was found to be competitive in its performance relative
to the other models on the other spike-in experiments.
Relative performance of the models compared in this study is discussed, as well
as relative computation times for each model.
(58 pages)
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INTRODUCTION

Microarray

Technology

Microarray technology (20) is used to quantify gene expression in individual
organisms.

These expression levels can be compared across groups of individuals

that differ in some way (e.g. healthy vs. diseased, control vs. treatment).

The

microarray can measure expression of all known genes of an organism simultaneously
by measuring the abundance of mRNA. A single gene is said to be differentially
expressed if its expression level, as measured by the intensity on the microarray, for
one group is significantly different from its expression level for another group.
Knowledge or understanding can be gained about the activity and biological roles
of a gene if it is found to be differentially expressed . This knowledge can then be
applied in areas of medicine and pharmaceutical research. For example, questions
about the causes and consequences of a disease, the effects that a drug will have on
an organism, and other gene related questions can be addressed (20).
To understand how microarray data is obtained, one must have a brief understanding of basic genomics (the study of organisms pertaining to the genome). A
genome contains information for all cellular structures and activities in an organism,
and is made up of long, paired strands of DNA . Included in these are one of four
nitrogenous bases, namely adenine, thymine, cytosine and guanine (A, T, C and G,
respective ly) . It is important

to note that each nitrogen base on one side of the

double-helix is paired with a corresponding base on the other side. Base A pairs with
base C, and base T pairs with base G. Genes, which are made up of segments of
DNA, contain the information needed to construct proteins.
When a gene is expressed, t he segment of DNA is transcribed into segments of
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mRNA, which, like DNA, contain four nitrogenous bases: adenine, uracil, cytosine
and guanine (A, U, C and G, respectively). These mRNA strands are translated into
a chain of amino acids, called a protein.
Using microarrays, gene expression is quantified by the abundance of mRNA.
There are different types of microarrays that yield gene expression data. The data
from this study come from the Affymetrix GeneChip (1). Each gene is represented by
a set of probe pairs placed in known locations on the microarray. For the Affymetrix
GeneChip, there are 11-20 probes in each probe-set.

Note that the terms "gene"

and "probe-set" are used interchangeably in this paper. Each probe pair contains
a perfect match probe (PM) and a mismatch probe (MM) . PM probes consist of a
unique sequence of 25 nitrogen bases, exactly matching that of the gene it represents,
and is copied millions of times in each location the probe is placed. MM probes are
the same as PM probes, but differ at the middle nitrogen base on each sequence.
The microarray is then washed in mRNA from a biological sample, which has been
labeled by fluorescent dye (used by some statistical models to account for noise on the
array). Hybridization occurs when a probe is successfully matched with a segment
of mRNA from the sample. The intensity at which the dye fluoresces when scanned
with a laser corresponds to the amount of hybridization that occurs. The amount of
hybridization for the probe-set is summarized into the expression of one gene (26).
This technology is commonly used in agricultural research (9). Recently, it was
implemented in a research study on the cloning of cattle using nuclear transfer (NT)
(2). Among other purposes, a main goal for using microarrays in the research is to
identify a genetic basis for successful NT pregnancies by examining gene expression.

3

Statistical

Models

The analysis of differential expression in genomic data requires the use of statistical models. The more common statistical models used in identifying differential
expression assume larger sample sizes than are practical in expensive NT studies and
other studies in which acquiring a large number of samples is impractical.
The different statistical models for identifying differential expression can be
placed into three main classes: probe-set level, weighted probe-set level and probe
level. Probe-set level and weighted probe-set level models account for information
of the probe-sets, but fail to account for information of the individual probes. This
information may be valuable in situations, as in the NT study, where there are a relatively small number of samples. Probe level models take into account this information
and may be more appropriate in these situations .
The main objective of this study is to compare these different classes of statistical models and characterize data structures in which the different classes are more
appropriate .

4

DATA
There are different classes of datasets that were used in the study. These classes
included an experimental dataset using bovine NT samples, spike-in data, and simulated data . For this study, all data considered are of a simple treatment vs. control
design, described in the Introduction section.

Bovine Data

The motivating dataset, as mentioned in the Introduction, was taken from an
exper iment in the cloning of cattle (NT) . There were 4 arrays (samples) representing
clones and 3 representing non-clones . For each array, a tissue sample was taken and
prepared from coty ledon (part of the uterin e side of the placenta) in an impregnated
cow. Four of these pr egnancies involved NT and three were control making 7 total
samp les.
For these data , we are interested in differential expression across treatments.
That is, we are interested in identifying genes that behave differently in the NT
samples than in the non-NT samples. Th ere are 24,128 genes on each array and the
type of microarray used was the Affymetrix Bovine array.

Spike-In Data

These datasets are used to validate statistical models by verifying their ability to
classify differentially expressed genes . In spike-in experiments, the "truth" is known
a priori . In particular, a set of genes whose mRNA has been artificially increased in
a sample to be hybridized onto the array are said to be "spiked-in." The "expression
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level" of these genes can be controlled by modifying their spike-in concentration.
Thus their "expression levels" can be made to change across "treatments."

That

is, they are known to be differentially expressed . Hence it can be verified how well
statistical models identify differentially expressed genes in general by how well they
find spiked-in genes in these types of experiments.
Data from three spike-in experiments were used to compare the different statistical models. The Affymetrix HGU95A spike-in experiment consists of 59 arrays and
12,626 genes on each array out of which 14 genes were spiked-in . For this experiment,
only 8 arrays were used. The Affymetrix HGU133A spike-in experiment consists of
42 arrays, out of which only 6 were used. In this experiment, 42 out of 22,300 total
genes were originally known to be spiked-in, and in Chen and McGee (2006), 22 more
genes were identified as being spiked-in. For our study, all 64 spiked-in genes were
considered.
The third and final spike-in dataset used was the Golden Spike dataset (7).
There has been some controversy with the veracity of this experiment.

In Pearson

(2008), the dataset was claimed to be flawed due to unrealistically high levels of
spike-in concentration and the differentially expressed spike-ins being all up-regulated
(having higher expression in one treatment group than the other) . However, it is still
sometimes used as a tool in comparing statistical models. This experiment consists
of 6 arrays and 1331 out of 14010 genes were spiked in.

Simulated Data

It was originally thought that simulated data would be used in this study because
it would allow for the controlled creation of different variability structures seen in
data, e.g. adjusting variability across arrays vs. variability within arrays . However,
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Fig. 1: Variability in six datasets: (top row) Affymetrix HGU95A spike-in exper iment ,
Affymetrix HGU133A spike-in experim ent , th e Golden Spike datas et , (bottom row)
GSE5015 , GSE5245 and the Bovine dat aset . Axes are on th e log scale. We can
see from t hese plots variability across arrays is genera lly less than variab ility within
arrays. Note th at different symbo ls (red trian gles) are used to show variability of
spiked-in genes in the 3 sp ike-in exper iments.

lookin g at variou s re al datasets (F igure 1), vari ability across arrays always seems to
b e sub stantia lly less than variab ility within arr ays .

Variability Within vs. Variability

Across

For t his st ud y, these variabilitie s were calculated using th e PM intensity values
an d gene expression values (PM int ensiti es and gene expr ession were pr eprocessed as
described in the Methods section). For variability across arrays , the variance of th e
set of expression values for one gene across all arr ays was taken. This was repeated
for each gene in the data set. Variability within array s was calc ulated on a per gene
ba sis. For each gene, the variance of PM int ensitie s in one array was taken.

The
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median of these variances was taken across arrays. This process was repeated for
each gene.
Six datasets were used to assess the variability structure (shown in the plots in
Figure 1). The three spike-in datasets and the bovine dataset described previously
were used. GSE5015 and GSE5245 are publicly available data from Gene Expression Omnibus (4). GSE5015 is a rat dataset consisting of 1,322 genes and 4 arrays.
GSE5245 is a mouse dataset consisting of 45,101 genes and 16 arrays.
Given that this is the case, i.e. there is only one variability structure, there is no
need to simulate data with a different structure. Note that it is possible to simulate
microarray data, but it was not necessary in the context of this study, due to the
availability of reliable spike-in data.

8

METHODS
As mention ed in the Introduction section, there are many different models for
identifying differentially expressed genes in a microarray experiment.

Due to the

motivation of this study being experiments with relatively small sample sizes, we
compared models at the probe level to account for information that may be lost at
the probe-set level, i.e. averaging across probes in a probe-set.

Note that all of

these models, with the exception of PL-LM and NFM, have been implemented in
R as packages in Bioconductor (12). In this section, we summarize the methods'
approaches to calculate test statistics for calculating differential expression.
The computational

steps taken to convert original probe-level intensities into

probeset-level estimates of gene expression on each array are called preprocessing.
There are various methods used for preprocessing.

A widely used method among

these is called RMA (14), which ignores MM intensities.

RMA preprocessing has

three steps: background correction, quantile-normalization

and median polish sum-

marization. There is often noise or artifacts on the array. Background correction is
done to remove any such noise. Quantile-normalization will remove the array effect
so that measurements across arrays are comparable.

These background corrected,

quantile-normalized intensities are returned on the log2 scale prior to the summarization step,which combines the probe values into a single summary for the probeset on
each array .

NFM

NFM (developed and presented for the first time in this work) uses a basic
structure in experimental design known as a nested factorial model. Here we have

9

the following model, for gene k:

(1)

l'ijl

= µ + ~ + sj(i) +Pi+ (TP)il + (SP)jl(i)

where the response, l'ijt, is the background-corrected, quantile normalized, log perfect
match probe intensity for probe l for the gene on array j under treatment level i, Ti is
the treatment effect, Sj(i) is the subject (array) effect nested within treatment,

Pi is

the probe effect, (TP)il is an interaction between treatment and probe, and (SP)jl(i)
is used as the error term. This model clearly takes into account any probe information
that may be lost at a probe-set level.
Since we are interested in identifying whether or not each gene is differentially
expressed across treatments, i.e. we are testing H0 : T1 = T2 , we can look at an
F-statistic for treatment.

This statistic can be obtained via REML estimation, as

implemented in the lme function of the nlme R package (23) . The degrees of freedom
for the numerator and the denominator are g-1 and
g

I:f=1 ( ni -1),

respectively, where

is the number of treatments and ni is the number of samples within treatment level i .

These F-statistics can be compared to an F9 ,z:r=i(n;-l)

distribution to obtain p-values .

In one of the spike-in experiments (HGU95A), NFM outperforms all other models
and is competitive with the other models in the other spike-in experiments compared
in this study (see Results). It is important to note that, due to the nature of the
nested design, an iterative process (REML) is undergone to obtain the F-statistics
for each gene. This iterative process takes some time and can be very slow given that
there are a very large number of factor levels, including a large number of probes per
gene on some array types.

10

PLM

PLM is a probe level model suggested in Bolstad (2004). To assess differential
expression across treatments , the per-gene model

(2)

is used, where Y;j is the background-corrected, quantile normalized, log perfect match
probe intensity for probe i of the gene on array j, ai is the probe effect and {Ji is the
array effect. Bolstad defines two test statistics used to test for differential expression,
i.e. to test Ho: Xi =

X2,where Xi is the

mean expression level in group 1 and

is the mean expression level in group 2 (i.e.

Xi - X2 is

X2

the log fold change across

treatments):

(3)

tPLMi

=

c'/3

---;:====

Jc'diag(t)c

and

(4)

tPLM2

c'/3
wFc'

= ---

{J is a vector of estimated array effects and :E is the portion of the estimated

variance/covariance matrix corresponding to

/3.The

length of vector c is the total

number of arrays in the dataset. The elements of c depend on how many arrays are
if array
if array j is in treatment group 1, _...!...
in each treatment. Element j of c is ...!...
n2
n1

j is in treatment group 2, and 0 otherwise. Note that ni is the number of samples in
treatment group 1. Also note that c' /3is the log fold change across treatments, and
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PLM is a very fast process since there is nothing more than some matrix computations, which are very efficient. Moreover, this model is very competitive with
other models compared in this study (see Results) . We can also use the fold change
as a way to identify differentially expressed genes; this will also be compared in the
Results section.

Limma/ eBayes (LE)
LE is a probeset-level method in which a hierarchical Bayesian model is used
to define a moderated test statistic for testing differential expression (27). First , we
assume the per-gene linear model:

(5)

where ~jk is the log expression level for gene k on array i in treatment group j, {31 is
the treatment effect and Tj is the treatment level, coded as a dummy variab le (e.g.

0/1). Note that Var(cij) =

a2.

We want to obtain estimates Jk, ak and Var(Jk)
covariate 1, these are:

and

Viof For gene

k and
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where dk is the residual degrees of freedom. Then , we define a test statistic:

t

(6)

-

k,l -

~

/Jk,l

~

O'k V

y

~ t dk

k 1, 1

We then assume a prior distribution on the precision:

where

s5and

do are estimated from the data (using all genes) using empirical Bayes

methods. We then form a posterior mean:

Then , to test for differential expression, we define a moderat ed t-statistic for each
gene as

(7)

LE is a very efficient method, meaning that it runs as fast as PLM . It is also a
very competitive model with the other models compared (see Results) .

PL-LM
This probe-level linear model (PL-LM) is proposed in Lemieux (2006). It uses
the linear model to estimate the treatment effect directly, using information on the
probe-level:

(8)
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where the l'ijt are defined as above, ai is a combination of the expression level of the
gene across arrays and specific probe affinities and Tj is the effect of treatment j.
The treatment effect is then estimated using standard least-square procedures. We
plot these against the average log probe-set intensities to reveal a Gaussian mixture
model (see Figure 2). The plot on the left of Figure 2 shows 3 clusters of points. The
dense cluster around where the treatment effect is O and the cluster just below this
are most likely to contain genes that are not differentially expressed.
To fit the Gaussian mixture, after using such plots to decide the number of
components to include, we used the implementation in the R package mclust (10). To
test for differential expression, we use as the test statistic the conditional probability
that the gene belongs to the most extreme cluster (in terms of the treatment effect)
from the Gaussian mixture model.
The drawback to this model is that it can not be automated. One has to manually
choose the number of components to use in the Gaussian mixture model by looking
at these plots. It is not always clear how many components to choose for the mixture
model (see Figure 2). Based on recommendations from Lemieux, anywhere in the
order of 5-15 components seems reasonable (personal communication).

PUMA
Propagating Uncertainty in Microarray Analysis, or PUMA, as described in Liu
et al (2005, 2006), accounts for uncertainty of the measured value of each gene when

doing these experiments, and includes a probe-specific parameter in a probabilistic
model . The model accounts for information from both the PM and MM probes,
instead of treating MM probes as background.
The first step of PUMA is to preprocess the raw microarray data using a method
called multi-chip modified gamma Model for Oligonucleotide Signal, or multi-mgMOS.
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Fig. 2: Choosing the number of components for the Gaussian mixture model has a
varied difficulty. The plot on the left comes from the Golden Spike dataset, and it is
fairly clear that 3 components would do well in the mixture model. However, looking
at the plot on the right , which comes from the HGU95A experiment, it is not at all
clear how many components to choose.

This method uses a hierarchical Bayes model to obtain the expression level for each
gene.
After this preprocessing, PUMA uses a hierarchical model to obtain the posterior
distribution on µ 1 , the mean expression value of a gene for treatment j. Since this
posterior distribution cannot be written in closed form , an EM algorithm (using
MCMC) is used to approximate the distribution.

The test statistic for each gene

is then the probability that the gene is up-regulated (or down-regulated), e.g. the
probability that µ 1 > µ 2 ( or µ 2 > µi), is then calcu lat ed. These test statistics can be
converted into a "P-like-value," which is the probability that each gene is differentially
expressed . The P-like-values are more comparable to the P-values returned from other
methods , in that smaller values represent stronger evidence of differential expression.
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These methods have been implemented into an R-package, puma.
One drawback of PUMA is that it is very computationally- and therefore timeexpensive. For the datasets listed above, the process took anywhere between 1-3
hours each time it is run. Although the model takes into account information for
each probe-pair (PM and MM), it did not significantly outperform the other models
on the three datasets compared (see Results).

PLW

As with some of the other methods compared here, the probe-level locally moderated weighted median-t method (PLW) proposed in Astrand et al (2007) uses a
hierarchical Bayes model to obtain a moderated, weighted t-statistic for each PM
probe .
As with other models , the PM intensities need to be preprocessed before any tests
for differential expression are performed. Here we use RMA preprocessing methods.
With the background-corrected,

quantile normalized data, a weighted, moderated

test statistic is calculated for each probe. The test statistic for whether or not gene k
is differentially expressed is then calculated by taking the median of the moderated
test statistics for each probe within gene k. This method has also been implemented
into an R-package, plw.

Other Methods

The naive fold change (FC) across treatments can also be used for identifying
differentially expressed genes . For this study, the fold change was calculated as in
PLM, e.g.

c'/J,where c and /Jare

as previously described.
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Using the inverse variance of the RMA expression levels as weights (21), one can
modify equation 5 to perform a weighted probeset-level test for differential expression.
Note also that these weights can be used to form a weighted fold change for identifying
differentially expressed genes. Previous results (not shown) have demonstrated that
these methods do not perform well against the other models compared in this study.
Due to this, and the fact that it is extremely computationally expensive to obtain
these weights, these methods were omitted from this study .
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RESULTS

In order to understand how well each of the previously defined models can identify
differentially expressed genes, each was compared simultaneously by comparing the
true positive rate (TPR) versus the false positive rate (FPR) on the three spike-in
datasets described previously. For each model, a test statistic was obtained for each
gene and the absolute values of these test statistics were sorted in increasing order.
The TPR and FPR values were defined as follows, as in Bolstad (2004): For the
entire set of sorted test statistics, count the number of spike-in genes that are called
significant (i.e. that are in the set being considered) and divide that by the total
number of spike-in genes. Call that the TPR for the first set of sorted test statistics.
Count the number of non-spike-in genes called significant and divide that by the total
number of genes that are not spiked-in. Call this the FPR for the first set of sorted
test statistics . Then omit the test statistic with the smallest absolute value and obtain
a TPR and FPR for that subset of test statistics.

Repeat this process by removing

the test statistic with the smallest absolute value each time and obtaining TPRs and
FPRs for each subset of test statistics . For the last iteration, the subset will only
contain one test statistic.

The total number of TPR and FPR values obtained will

be equal to the total number of genes in the dataset .
For each spike-in dataset, an ROC curve was created to assess visually how well
each model performed. The ROC curve is a plot of TPR vs. FPR. A higher curve
indicates higher performance in identifying differentially expressed genes .

HGU95A

For the HGU95A dataset, a total of 8 arrays were used (i.e. 2 treatments with
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HGU95A Spike-in Data
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Fig. 3: Th ere were 8 arrays comp ared in the HGU95A exp eriment. TPR and FPR
values were averaged over all 3 x 3 compar isons. In each compar ison, one array from
each treatment was left out. Th ere were a tota l of 16 comp ar isons. We can see that
NFM clearly outperforms the other models.

4 arrays in each treatment).

Inste ad of obtaining test stat ist ics on all 8 arrays, test

statist ics and therefore TPR and FPR were obtained for all comb inat ions of 3 x 3
comp arisons . That is, one array from trea tment 1 and one array from treatment 2
were left out for each of 16 comparisons and all mod els were perform ed on these data .
These TPR and FPR were the averages across all 16 combinations.
By lookin g at Figur e 3, NFM clearly outperforms all other mode ls. Next, LE
and both PL M l and PLM2 perform almost equally as well. Th en , using only the fold
change across treatments performs bett er t han th e last 3, PL-LM , PUMA and PLW .
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HGU133A Spike-in Data
All 64 Spike-in Genes
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Fig. 4: There were 8 arrays compared in the HGU133A experiment. TPR and FPR
values were averaged over all 2 x 2 comparisons. In each comparison , one array from
each treatment was left out. There were a tota l of 9 comparisons.

Note that PUMA performed far worse than the other models. Note also that all of
the spiked-in genes are identifiable (TPR values reach 1). This could be an indi cat ion
that the HGU95A exper iment is a useful too l in compar ing statistical models.

HGU133A

For the HGU133A dataset, a total of 6 arrays were used. As in the HGU95A
dataset , TPR and FPR values are averages of all 2 x 2 (9 total) compar isons. Looking
at Figure 4, we can see that no model systematically outperforms any other model.
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HGU133A Spike-in Data
30 Spike-in Genes
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Fi g. 5: Th ere were 8 arrays comp ared in the HG U133A experim ent . TPR and FPR
values were averaged over all 2 x 2 comp ar isons. In each comparison , one array from
each t reatm ent was left out. Th ere were a tota l of 9 comp arisons. 30 out of 64 spike-in
genes were used .

NFM clearly und erperform s comp ared to the ot her mod els. Thi s dataset also seems t o
give the mod els some pro blems with ident ifying all 64 spiked-in genes, bu t the mod els
p erform much better on thi s dat aset th an on th e Gold en Spike data supporting t he
argument th at th ere are some clear probl ems with th e Gold en Spike exp eriment , as
pr eviou sly mention ed. Becau se of thi s, all mod els were run on th e dat aset again ,
using only tho se spike-in genes th at had a grea ter spike-in concentra tion , a total of
30 out of 64 spike-in genes. From Figur e 5 we see th at all mod els have a hard er t ime
identifying the 30 spike-in genes than th e 64 spike-in genes from Fi gur e 4.
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Golden Spike Data
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Fig. 6: Ther e are a tota l of 6 arrays in the Golden Spike experiment. TPR and FPR
values were average d over all 2 x 2 compar isons. In each compar ison, one arra y from
each treatment was left out . Th ere were a tota l of 9 comp arisons.

Golden Spike

Th e Gold en Spike exp eriment , as mention ed in the Dat a sect ion , was claimed
to be flawed in Pearson (2008). The ROC curve (Figure 6) is an indi cat ion of this
as well (Note that TPR and FPR are averages across all 2 x 2 comparisons as in
the HGU133A data set).

None of the mode ls perform very well, although PL -LM

performed much better t han any oth er model compared.

However, only at t he far

right of the graph did any of the models ever reach a TPR of 1, meaning that the
mode ls ident ified all of the spike-in genes as differentia lly expres sed only when looking
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Fig. 7: Histograms and Quantile plots from a p ermut at ion test for two sampl e genes
show that t he F-di str ibution with (g - 1) and I:;=1 ( n i - 1) degre es of freedom is
a reasonable approx imat ion for test statist ics from t he FM model. This test was
p erformed on t he Bovin e data.

at t he ent ire set of genes. This could be an indi catio n that the Golden Spike dataset
is not a useful too l in compar ing stat ist ical models since some of the spiked-in genes
are not eas ily ident ifiab le as differentiall y expressed.

Bovine Data

Th e Bovine data set is an experimental datase t as mention ed in the Data section, that consists of 24128 genes on each of 7 arrays.

Th ere are two treatment

levels, contro l and clone, with 3 and 4 samples in each , respective ly. Based on strong
p erforman ce on th e spike-in data , NFM was performed on these data .
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As noted in the Methods section, NFM can be used to obtain an F-statistic and
therefore P-values can be obtained for each gene by comparing the test statistic to
an F-distribution with (g - 1) and

I:f=1 (ni

- 1) degrees of freedom. To justify this

parametric assumption, a permutation test was done. NFM was performed on the
Bovine data for all possible permutations of the treatment effect; i.e. the vector of
treatment labels (0, 0, 0, 1, 1, 1, 1) was permuted 35 times (the maximum number of
permutations) and NFM was run for each. A test statistic was obtained for each
permutation and these F-statistics were compared to an F-distribution with 1 and 5
degrees of freedom (see Figure 7).
The permutation shows that the aforementioned F-distribution is a good approximation for the NFM model. Histograms and quantile plots for sample genes (Figure
7) show this. Thus, test statistics can be compared to the F-distribution to obtain a
P-value for each gene to test whether or not the gene is differentially expressed. Note
that these P-values are still subject to multiple comparison issues (11).
The F-statistics for non-spike-in genes in each each of the 3 spike-in datasets (see
Figure 8) were compared to the F-distribution. Note that the null hypothesis of "no
differential expression" is known to be true for these non-spike-in genes. These plots
help support the notion that the F-distribution with (g - 1) and

:Eini

- 1 degrees

of freedom is a good approximation for the NFM test statistics, where g is the total
number of treatments and ni is the total number of arrays in the ith treatment.
A histogram, a heatmap, and a volcano plot were constructed (figures 9, 10 and
11, respectively) to summarize the Bovine NFM results. Figure 9 shows a histogram
of P-values from running NFM on the Bovine data.

The shape of the histogram

denotes that nothing will be found significant (i.e. no differentially expressed genes)
after an FDR adjustment. It may be possible to filter genes to reduce severity of the
correction and increase statistical power (13).
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Fi g. 8: Qu anti le plot s for th e HGU95A , HGU13 3A, and Golden Spike datase t s show
th at th e F-di st ribu t ion is a good approxim ation for th e NFM test stat ist ics.

Th e heatma p shows 25 genes wit h the largest F-stat ist ics.

Colors repr esent

expression after RMA preprocess ing, ra nging from dark red for low expr ession to dark
blu e for high exp ression . We ca n see t hat t here is some pr edictiv e abilit y at pr edictin g
a clone versus a contro l. Th e volcano plot ::,hows a few genes t hat are good ca ndid at es
for be ing clas sifi d as different ially expr essed . Darker colors indicate higher density
in t hat area . T he crea tion of t hese plots is impl emented using R-p ackages geneplotte r
(16) an d RColor Brewer (8) .
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Histogram of P-values from NFM
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Fig. 9: A Histogram of the P-values from running NFM on the Bovine data.
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Bovine Data Top 25: NFM
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Volcano Plot of Bovine Data: NFM
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Fig. 11: Volcano plot of all genes in Bovine data shows a few candidate genes for
being classified as differentia lly expressed. Darker colors represent higher density.
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DISCUSSION
The nested factorial model (NFM) was shown in the Results section to be a
competitive statistical model for identifying genes that are differentially expressed
when sample sizes are small. In the case of the HGU95A spike-in experiment, this
model was found to outperform all other models that were compared in this study.
In the HGU133A data, NFM performed more poorly than the other models. With

this dataset, the REML was not always able to converge. Many genes were given no
F-statistic due to this problem. This could be the cause of the problems NFM had
identifying the spike-in genes in the HGU133A dataset. In the Golden Spike dataset ,
NFM performed more poorly than the other models; however, the dataset is said to
be flawed and only PL-LW systematically performed better than any other model.
One strength of NFM is that a test statistic is obtained that can be compared to a
parametric distribution to obtain P-values . The one drawback to the model, as noted
previously, is the iterative process it uses to obtain these test statistics that causes a
long wait time , up to two hours for each time the model is run, and sometimes has
problems with convergence.
PLM was also shown to be very competitive, though it only outperformed NFM
in the Golden Spike dataset. In the HGU95A dataset, it performed about the same as
Limma/ eBayes and outperformed all other models except NFM . One strength that
PLM has is that it is very fast. One can obtain t-statistics and since there is no
iterative process, to obtain these is very time-inexpensive.

The same can be said

about LE. It performs well on all models and is also very fast.
PUMA was very slow and did not perform the best on any one dataset.

On

the HGU95A data, PUMA was clearly outperformed by all models. Run times were
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anywhere between 1 to 3 hours. Another drawback from PUMA is that test statistics
and P-like-values are harder to interpret than NFM or other models.
PL-LM outperformed the other models only on the Golden Spike data, yet was
outperformed on the HGU133A data. Computation times were relatively fast compared to PUMA and NFM. Similarly, PLW had computation times that were not
unlike PL-LM. This model was competitive with the rest of them on the HGU133A
experiment; however, it was outperformed by all save PUMA and PL-LM on the
HGU95A experiment.
For spike-in experiments, comparisons on different statistical models seems to be
more meaningful when models are able to identify all spiked-in genes. The Golden
Spike experiment was clearly flawed, which made it difficult to identify these genes.
For experiments with small sample sizes, e.g. the Bovine data, it is clearly more
effective to use a probe-level model to identify candidate genes for being differentially
expressed. Information is not lost due to averaging over probes in a probe-set. NFM
seems to be a good model for these small-sample situations as it takes into account
the probe effect, as best shown in Figure 3.
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FUTURE WORK

Tiling arrays are another type of array that contain genomic information . These
arrays contain 25-60 base pair probes that are used to detect the presence or absence of transcription, whereas regular microarrays contain 25 base pair probes (25).
There are typically larger numbers of probes for each gene than on traditional gene
expression arrays, which tend to have 11-20 probes per gene. Moreover, the tiling
array uses probes whose sequences overlap and cover (or "tile") the entire genome of
an organism. NFM is a very useful tool that can be applied to tiling array data to
identify differentially expressed genes. It has already been applied to Daphnia tiling
array data with promising results (not shown).
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RCODE

True Positives and False Positives
This function is used to obtain true posit ive and false positiv es rates for all
models. Arguments pass ed to the function are an AffyBatch object, a vector for
the levels of treatment

1 and treatment 2 (e.g. (1, 2, ... , i)), a vector of O's and l's

representing the treatment effect (e.g. (0,0,0, 1, 1, 1, 1)), a string-vector of names for
spike-in genes, the number of mixes for the mixture model, and whether or not to
print progress and run-time in the R-console.
roe.avg<-

function(data,trt1,trt2

, trt,gn

. spike,nmix=7,verbose=FALSE)

{

### Load necessary
require(affyPLM)
require(nlme)
require (limma)
require(mclust)
require(puma)
require(plw)
### Define

libraries

a few things

ncom <- length(trt1)*length(trt2)
gn . sub <- geneNames(data)
. spike)
tO <- is.element(gn.sub,gn
<- gn.sub[!is.element(gn
gn.nonspike
###Setup

storage

.s ub,gn .s pike)]

matrices

tp.plml <- matrix(O,length(gn.sub),ncom)
. sub),ncom)
fp.plml <- matrix(O,length(gn
tp .plm2 <- matrix(O,length(gn.sub),ncom)
fp . plm2 <- matrix(O,length(gn.sub),ncom)
tp . FC <- matrix(O,length(gn.sub),ncom)
fp.FC <- matrix(O,length(gn.sub),ncom)
tp.le <- matrix(O,length(gn.sub),ncom)
. sub),ncom)
fp . le <- matrix(O,length(gn
matrix(O,length(gn.sub),ncom)
<tp.nfm
. sub),ncom)
fp . nfm <- matrix(O,length(gn
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<- matrix(O,length(gn.sub),ncom)
tp.lemieux
<- matrix(O,length(gn.sub),ncom)
fp.lemieux
tp.puma <- matrix(O,length(gn.sub),ncom)
fp.puma <- matrix(O,length(gn.sub),ncom)
tp.plw <- matrix(O,length(gn.sub),ncom)
fp.plw <- matrix(O,length(gn.sub),ncom)
### Start loop; this will go through all methods
### and return a dataframe of tp and fp values averaged
### over cominations and a list of all tp and fp values.
begintime <- date()
col.num <- 0
for(r in trt1){
begintime <- date()
for(q in trt2){
col.num <- col . num + 1
begin .plm <- date()
[-q])]
,(trt2+length(trt1))
fitPLM(data[,c(trt1[-r]
set<+probes,subset=gn.sub,output.param=list(varcov="chiplevel"))
eset <- coefs(set)
<- eset[,1:length(trt1[-r])]
trt.1
<- eset[,length(trt1[-r])+1:length((trt2+length(trt1))[-q])]
trt.2
n1 <- ncol(trt.1)
n2 <- ncol(trt.2)
c <- t(c(rep(-1/n1,n1),rep(1/n2,n2)))
fc <- eset%*%t(c)
vc <- varcov(set)
###Adda

line

cat ("Iteration

that

states

iteration

and time

: ", col . num, "Time:", date(),'

\n')

#1

### Compute tp . plml and fp .plm1
t.plm1<-rep(O,nrow(eset))
for(i in 1:nrow(eset)){
t . plm1[i] <- fc[i]/sqrt((c%*%diag(diag(vc[[i]])))%*%t(c))
}

templ <- sort(abs(t.plm1),decreasing=F,ind=T)
T.plm1 <- temp1$x
ord.1 <- temp1$ix
. 1]
names . 1 <- rownames(eset)[ord
for(k in 1:length(names.1)){
<- names.1[k:length(names.1)]
gn.sig.k
.num] <- sum(is.element(gn.sig.k,gn.spike))/
tp.plml[k,col
(length(gn.spike))

,PM--1+samples
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<- sum(is.element(gn.sig.k,gn.nonspike))/

fp.plm1[k,col.num]
(length(gn.nonspike))
}

###

Compute tp.plm2

and fp.plm2

t.plm2<-rep(O,nrow(eset))
for(j in 1:nrow(eset)){
<- fc[j]/sqrt((c%*%vc[[j]])%*%(t(c)))
t.plm2[j]
}

temp2 <- sort(abs(t.plm2),decreasing=F,ind=T)
T.plm2 <- temp2$x
ord.2 <- temp2$ix
names.2 <- rownames(eset) [ord.2]
for(k in 1:length(names.2)){
<- names.2[k:length(names.2)]
gn.sig.k
<- sum(is.element(gn.sig.k,gn.spike))/
tp.plm2[k,col.num]
(length(gn.spike))
<- sum(is.element(gn.sig.k,gn.nonspike))/
fp.plm2[k,col.num]
(length(gn.nonspike))
}

###

Get the TPR and FPR for the fold

changes

temp3 <- sort(abs(fc),decreasing=F,ind=T)
FC <- temp3$x
ord.FC <- temp3$ix
rownames(eset)[ord.FC]
names.Fe<for(k in 1:length(names.FC)){
<- names . FC[k:length(names . FC)]
gn.sig.k
tp . FC[k,col . num] <- sum(is.element(gn.sig.k,gn.spike))/
(length(gn.spike))
. sig.k,gn .nonspike))/
fp .FC[k,col.num] <- sum(is.element(gn
(length(gn.nonspike))
}

end.plm <- date()
if(verbose==TRUE){
time for plm1, plm2 and fc:
cat("Starting
cat("Ending time for plm1, plm2 and fc:

11

,begin . plm, 11 \n")
,end.plm, 11 \n")

11

}
###
###

This portion
non-weighted

begin.limma

of the function
limma/ebayes.

<- date()

will

get the TPR and FPR for the
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eset.sub

<- eset[is.element(rownames(eset),gn.sub),J

### need to make sure the rows of eset.sub
### order as wt.mat

are in the same

t2 <- order(rownames(eset.sub))
<- eset.sub[t2,]
eset.sub
### Now fit

model

c(rep(O,length(trt1[-r])),rep(1,length(trt2[-q])))
type<cbind(Intercept=1,type=type)
design<### Do non-weighted

limma/eBayes

lmFit(eset.sub,design)
fit<<- eBayes(fit)
e.fit
. sub),coef=2,adjust="BH")
topTable(e . fit,n=nrow(eset
top.all<= gn . sub)
data.frame(ID
fl<= top.all$t)
= top.all$ID,t
f2 <- data.frame(ID
f <- merge(f1,f2,sort=FALSE,all.x=FALSE)
###Get tp.le
t.le

and fp.le

<- f$t

temp4 <- sort(abs(t.le),decreasing=F,ind=T)
T.le <- temp4$x
ord . le <- temp4$ix
rownames(eset)[ord.le]
names.le<for(k in 1:length(names.le)){
<- names.le[k:length(names.le)]
gn.sig.k
. k,gn.spike))/
<- sum(is.element(gn.sig
tp.le[k,col.num]
(length(gn . spike))
<- sum(is.element(gn.sig.k,gn.nonspike))/
fp.le[k,col.num]
(length(gn.nonspike))
}

end.limma <- date()
if(verbose==TRUE){
,begin.limma,
time for limma/eBayes:
cat("Starting
time for limma/eBayes: ",end.limma,"\n")
cat("Ending
11

11

\n")

}

### This portion of the function
Model
### Nested Factorial
### Get the background
begin .nfm <- date()

corrected,

will

get the TPR and FPR for the

normalized

log pm intensities
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,(trt2+length(trt1))
a.bg <- bg.correct(data[,c(trt1[-r]
a.bg.norm <- normalize.AffyBatch.quantiles(a.bg,'pmonly')
pm<- log(pm(a.bg.norm,gn.sub),2)
pmindex(data,gn.sub)
pm.index<nprobes.k <- matrix(nrow=length(gn.sub))
### Define starting
for

and ending probes

[-q])] ,'rma')

for each gene

(j in 1:length(gn.sub)){
<- length(pm.index[j]
nprobes.k[j]

[[1]])

}

<- rep(O,length(gn.sub))
t.start
<- 1
t.start[1]
for (j in 2:length(gn.sub)){
<- t.start[j-1]+nprobes.k[j-1]
t.start[j]
}

t.end

<- t.start+nprobes.k-1

### Get tp.nfm

and fp.nfm

f .nfm <- rep(O,length(gn.sub))
for(i in 1:length(gn.sub)){
,]),
:t.end[i]
A<- factor(rep(colnames(pm[t.start[i]
,])))
:t.end[i]
each=nrow(pm[t.start[i]
:t.end[i]
TRT <- factor(rep(trt,each=nrow(pm[t.start[i]
,])),
:t.end[i]
P <- factor(rep(c(1:nrow(pm[t.start[i]
:t . end[i] ,])))
ncol(pm[t.start[i]
:t.end[i] ,])
Y <- as.vector(pm[t.start[i]
nfm<-try(lme(Y-TRT*P,random=-11A/TRT),silent=TRUE)
if(class(nfm)=="try-error"){
nfm2 <- try(lme(round(Y,9)-TRT*P,random=-11A/TRT),
silent=TRUE)
if(class(nfm2)=="try-error"){
nfm3 <- try(lme(round(Y,6)-TRT*P,random=-11A/TRT,
silent=TRUE),silent=TRUE)
if(class(nfm3)=="try-error"){
<- NA
f.nfm[i,col.num]
}else{
#For 3rd if
<- anova(nfm3)$F[2]}
f.nfm[i,col.num]
}else{
#For 2nd if
<- anova(nfm2)$F[2]}
f.nfm[i,col.num]
}else{
#For 1st if
<- anova(nfm)$F[2]}
f.nfm[i,col.num]
}

temp<-

sort(abs(f.nfm),decreasing=F,ind=T)

,])))
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F.nfm <- temp$x
ord.nfm <- temp$ix
names.nfm <- rownames(eset)[ord.nfm]
for(k in 1:length(names . nfm)){
<- names.nfm[k:length(names.nfm)]
gn.sig.k
<- sum(is.element(gn.sig.k,gn.spike))/
tp.nfm[k,col.num]
(length(gn.spike))
. sig.k,gn.nonspike))/
<- sum(is.element(gn
fp.nfm[k,col.num]
(length(gn.nonspike))
}

end.nfm <- date()
if(verbose==TRUE){
model: ",begin.nfm,"\n")
time for the nested factorial
cat("Starting
model: ",end.nfm,"\n")
time for the nested factorial
cat("Ending
}

Get tpfp

###

begin.lem

for Lemiuex

<- date()

,(trt2+length(trt1))
d . index <- pmindex (data[,c(trt1[-r]
gn.sub)
<- normalize.quantiles(log2(exprs(data[,c(trt1[-r],
ndata.quantile
[-q])J)))
(trt2+length(trt1))
(x) as.numeric
function
d.data <- sapply (names (ct.index),
,]))
(ndata.quantile[d.index[[x]]
(x) dim
function
d . nb_probe <- sapply (names (d.index),
. index[[x]] ,])[1])
(ndata.quantile[d
(x) mean
function
d.avg <- sapply (names (d.index),
(d .data [ [x]J))
, (trt2+length(trt1))
(data[,c(trt1[-r]
dee<- arrays.analysis
, length(trt1[-r])+1:length((trt2+length(trt1))
1 : length(trt1[-r])
. avg)
gn.sub,d.data,d.nb_probe,d
. avg)
.mix(dec,nmix,d
gauss
<t.lemieux
T.lemieux <- sort(t.lemieux,FALSE)
names.1 <- names(T.lemieux)
for(k

in 1:length(names.1))

{

<- names . 1[k:length(names.1)]
gn.sig.k
. k,gn.spike))/
<- sum(is.element(gn.sig
tp.lemieux[k,col.num]
(length(gn.spike))
<- sum(is . element(gn.sig.k,gn.nonspike))/
fp.lemieux[k,col.num]
(length(gn.nonspike))
}

[-q])J,

[-q])],
[-q]),
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end.lem <- date()
if(verbose==TRUE){
cat("Starting
time for Lemieux: ",begin.lem,"\n")
cat("Ending time for Lemieux: ",end.lem,"\n")
}

### Get tpfp

values

for PUMA

begin.puma<date()
data1 <- data[,c(trt1[-r]
,(trt2+length(trt1))[-q])J
varLabels(data1)
<- c("group")
pData(data1)
<- data.frame("group"=as
. character(type),
row .names= rownames(pData(data1)))
eset <- mmgmos(data1)
eset.mmgmos <- pumaNormalize(eset[gn.sub,])
eset.comb <- pumaComb(eset .mmgmos)
puma.res<pumaDE(eset.comb)
t.puma <- statistic(puma.res)
t.puma <- abs(t.puma- . 5)
tempi<sort(abs(t.puma)
, decreasing=F,ind=T)
I . puma<- temp1$x
ord . 1 <- temp1$ix
names . 1 <- rownames(t.puma)[ord.1]
for(k

in 1:length(names.1))

{

gn.sig.k
<- names . 1[k:length(names.1)]
tp.puma[k,col.num]
<- sum(is.element(gn.sig.k,gn
. spike))/
(length(gn.spike))
fp.puma[k,col .n um] <- sum(is.element(gn.sig.k,gn.nonspike))/
(length(gn.nonspike))
}

end.puma<-

date()

if(verbose==TRUE){
cat("Starting
time for Puma: ",begin.puma,"\n")
cat("Ending
time for Puma: ",end.puma,"\n")
}

### Get tpfp

begin.plw

values

for plw

<- date()

group<factor(c(rep(letters[1]
,each=length(trt1)-1),
rep(letters[2],each=length(trt2)-1)))
design<model.matrix(~group-1)
contrast<matrix(c(1,-1),1,2)
### Fit function
plwFit <- plw(data[,c(trt1[-r]
,(trt2+length(trt1))[
-q])J ,design=design,contrast=contrast,epsilon=1e-05,verbose=FALSE)
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medianT<-plwFit$medianT
sort(abs(medianT),decreasing=F,ind
temp!<T.plw <- temp1$x
ord.1 <- temp1$ix
names(medianT)[ord.1]
names.!<-

=T)

for(k in 1:length(names.1)){
<- names.l[k:length(names.1)]
gn.sig.k
<- sum(is.element(gn.sig.k,gn.spike))/
tp.plw[k,col.num]
(length(gn.spike))
<- sum(is.element(gn.sig.k,gn.nonspike))/
fp.plw[k,col.num]
(length(gn.nonspike))
}

end.plw <- date()
if(verbose==TRUE){
time for PLW: ",begin .plw,"\n")
cat("Starting
cat("Ending time for PLW: ",end.plw, "\n")
}

}
}

###

endtime <- date()
time:
cat('Starting
time:
cat('Ending

' \n')
begintime,
'\n ' )
endtim e , ' \n',

Define ave r age values

for all

nl X n2 combination

s

av . vec <- rep(l/ncom,ncom)
<- tp .plml %*%av . vec
tp.plml.avg
fp . plml.avg <- fp.plml %*%av.vec
tp.plm2 . avg <- tp .plm2 %*%av . vec
<- fp.plml %*%av . vec
fp.plm2.avg
tp . FC.avg <- tp . FC %*%av . vec
fp.FC . avg <- fp.FC %*%av.vec
tp . le.avg <- tp . le %*%av.vec
<- fp.le %*%av.vec
fp.le.avg
tp . nfm . avg <- tp.nfm %*%av.vec
fp .nfm . avg <- fp.nfm %*%av . vec
tp . lemieux.avg <- tp . lemieux %*%av .vec
fp . lemieux.avg <- fp . lemieux %*%av .vec
tp.puma.avg <- tp.puma %*%av.vec
fp .puma.avg <- fp . puma %*%av . vec
tp .plw . avg <- tp.plw %*%av.vec
<- fp . plw %*%av.vec
fp.plw.avg
. plm2.avg,tp.FC.avg,
tpfp.mat <<- data.frame(tp.plm1.avg,tp
tp . le . avg,tp . nfm.avg,tp.lemieux.avg,tp.puma.avg,tp.plw.avg,
, fp.nfm.avg,
fp.plm1 . avg,fp.plm2 . avg,fp . FC.avg,fp.le.avg
.plw.avg)
fp . lemieux.avg,fp.puma.avg,fp
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list(tp.plm1=tp.plm1,fp.plm1=fp.plm1,tp.plm2=tp.plm2,
tp.le=tp.le,fp.le=fp.le,
tp.FC=tp.FC,fp.FC=fp.FC,
tp.nfm=tp.nfm,fp.nfm=fp.nfm,tp.lemieux=tp.lemieux,
fp.lemieux=fp.lemieux,tp.puma=tp.puma,fp.puma=fp.puma,
tp.plw=tp.plw,fp.plw=fp.plw)
}

ROC Curves
This code contains the necessary steps to calling the roe.avg function (above)
and creating the ROC curves in the figures above.
### Need to source
### Need to define

roe.avg function
for Lemiuex
functions

(probe_name, ndata,
function
one.probe.analysis<FALSE) {
= 0, plot=
d.nb_probe,d . avg,offset
#cat ( 11Analyzing: 11 , probe_name, "\n")
(y = d.data[[probe_name]])
pm_frame <- data.frame
nb_probe <- d.nb_probe[[probe_name]]
nb_chip <- length (pm_frame$y) / nb_probe

d.data,

pm_frame$design <- c (rep (0, length (pm_frame$y) / 2),
rep (1, length (pm_frame$y) / 2))
(pm_frame$y),
<- matrix (0, nrow = length
pm_frame$probe_affinity
ncol = nb_probe)
for (i in 1 :nb_probe) {
i] <- 1
(i, nb_probe * nb_chip, nb_probe),
pm_frame$probe_affinity[seq
}

#pm_frame$design
0, pm_frame,
+design+
1 <- lm (y - probe_affinity
offset)
pm_frame$design *
offset=
# cat (summary(l))
data . frame (coef = coef(l) [["design"]],
p.value = coef(summary(l))["design","Pr(>ltl)

11

])

}

arrays . analysis<ndata.quantile
ndata.quantile

function

(data,

{

a, b,gn . sub,d.data,d.nb_probe,d.avg)

<- log2 (exprs (data)[,c(a,b)])
(ndata.quantile,
<- normalize . quantiles

copy=

TRUE)

(x) one.probe.analysis
t (sapply (gn.sub, function
res.quantile<ndata.quantile,d.data,d.nb_probe,d.avg)))
11
coef"]))
<- cbind (d.avg, as.numeric(res.quantile[,
x.quantile
gives figure 2 **********
### Plot x.quantile

(x,
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return(x.quantile)
}

gauss.mix<-

function(x.quantile,ncomp,d.avg)

{

z_class

<- sample (c(1:ncomp),

length

(d.avg),

replace=TRUE)

z = unmap (z_class))
<- me ("VVV", x.quantile,
c.quantile
gn.comp <- apply(c.quantile$z,1,which.max)
log2 Intensity',
plot(x.quantile,cex=.2,pch=16,xlab='Average
=",r,"q
Effect',col=gn.comp)#,main=paste("r
ylab='Treatment
top.t <- which.max(abs(x.quantile[,2]))
<- which.max(c.quantile$z[top.t,])
best.i
c.quantile$z[,best.i]

=",q))

}

###
###
###
###

vectors . The following is for the
need to define treatment
To call the function,
object with
but it can be modified for any affybatch
dataset,
HGU95Aspike-in
in this ca
object,
Note that "data" is any affybatch
with 2 levels of treatment.
dataset.
the HGU95Aspike-in

trt1 <- 1:4
trt2 <- 1:4
trt <- c(rep(1,3),rep(2,3))
roc.avg(data,trt1,trt2,trt,gn.spike,
roe<### Plot

verbose=TRUE)

stuff!!!

.mat$tp .plm1.avg,type='l')
plot(tpfp.mat$fp.plm1.avg,tpfp
,col=2)
.plm2 . avg,tpfp .mat$tp.plm2 . avg,type='l'
lines(tpfp.mat$fp
,col=3)
lines(tpfp.mat$fp.FC.avg,tpfp.mat$tp.FC.avg,type='l'
,col=4)
. mat$tp.le.avg,type='l'
lines(tpfp.mat$fp.le.avg,tpfp
,col=5)
.nfm . avg,tpfp.mat$tp.nfm.avg,type='l'
lines(tpfp.mat$fp
,col=6)
.mat$tp . lemieux.avg,type='l'
lines(tpfp.mat$fp.lemieux.avg,tpfp
lines(tpfp.mat$fp.puma.avg,tpfp.mat$tp.puma.avg,type='l',col=7)
,col=8)
.plw.avg,type='l'
lines(tpfp.mat$fp.plw.avg,tpfp.mat$tp

NFM

This function will obtain and return an !-statistic

and a p-value for a single

gene. The arguments passed to the function are a matrix of background-corrected,
quantile-normalized, log perfect match intensities for a given gene for all arrays in
the dataset and a vector representing the treatment effect.
nfm <- function(data,trt)
{

46

A<- factor(rep(colnames(data),each=nrow(data)))
TRT <- factor(rep(trt,each=nrow(data)))
P <- factor(rep(c(l:nrow(data)),ncol(data)))
Y <- as.vector(as.matrix(data))
nfm<-try(lme(Y-TRT*P,random=-11A/TRT),silent=TRUE)
if(class(nfm)=="try-error"){
f.nfm <- matrix(O,ncol=4)
}else{
f.nfm <- anova(nfm)[2,]
}

return(f.nfm)
}

Volcano Plots and Heatmap
This is th e code used to create the volcano plot and heatmap using the results
from running NFM on the Bovine dataset .
Load necessary libraries.
library(affy)
library(RColorBrewer)
library(geneplotter)
###

###
###
###

Need to obtain F-statistics
from NFMon an affybatch
object.
In this case the Bovine data was used.
Note that 'data'
is any
affybatch
object.

# Use the nested
factorial
model on the data
a.bg <- bg.correct(data,'rma')
a.bg.norm <- normalize.AffyBatch.quantiles(a.bg,'pmonly')
#

Get f . nfm for each gene in gn.sub

library(nlme)
gn <- geneNames(data)
f.nfm <- matrix(O,length(gn),2)
rownames(f . nfm) <- gn
colnames(f . nfm) <- c("F","P-Value")
trt <- c(0,0,0,1,1,1,1)
date()
for(i in 1:length(gn))
{

pm<- log(pm(a.bg.norm,gn[i]),2)
A<- factor(rep(colnames(pm),each=nrow(pm)))
T <- factor(rep(trt,each=nrow(pm)))
P <- factor(rep(c(l:nrow(pm)),ncol(pm)))
Y <- as.vector(pm)
nfm<-try(lme(Y-T*P,random=-11A/T),silent=TRUE)
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if(class(nfm)=="try-error"){
nfm2 <- try(lme(round(Y,9)-TRT*P,random=-11A/TRT),
silent=TRUE)
if(class(nfm2)=="try-error"){
nfm3 <- try(lme(round(Y,6)-TRT*P,random=-1IA/TRT,
silent=TRUE),silent=TRUE)
if(class(nfm3)=="try-error"){
f.nfm[i,]
<- NA
}else{
f.nfm[i,]
<- c(anova(nfm3)$F[2] ,anova(nfm3)$p[2])}
#For 3rd if
}else{
f.nfm[i,]
<- c(anova(nfm2)$F[2],anova(nfm2)$p[2])}
#For 2nd if
}else{
f.nfm[i,]
<- c(anova(nfm)$F[2] ,anova(nfm)$p[2])}
#For 1st if
}

date()

### Here, may want to write

f.nfm to a file

### Also need to obtain the fold
### In this case, was done using
library(limma)
eset <- exprs(rma(data))
tl <- order(rownames(eset))
eset <- eset[tl,]

change across
limma/eBayes

treatments

type< - c(l,1,1,1,0,0,0)
design<cbind(Intercep=l,type=type)
fit< - lmFit(eset,design)
e.fit
<- eBayes(fit)
top . all<topTable(e.fit,nrow(eset),coef=2,adjust="BH")
fl<data . frame(gn=top.all$ID,LFC=top
. all$logFC)
f2 <- data.frame(gn=gn,F=f
. nfm[,1] ,p=f.nfm[,2])
rownames(f2) <- 1 : nrow(f2)
f <- merge(f1,f2)
#Arrange fin
descending
t2 <- order(f$p)
F <- f[t2,]

order

of p-values

### Make a heat map of top 100 genes from Nested Factorial
t <- is.element(rownames(eset),F$gn[1:25])
small.eset
<- eset[t,J
hmcol <- colorRampPalette(brewer.pal(10,"RdBu"))(256)
cell< - c(rep("Control",3),rep("Clone",4))
csc <- rep(hmcol[50] ,ncol(small.eset))
csc [cell=="Clone"]
<- hmcol [200]
colnames(small . eset) <- cell
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heatmap(small.eset,scale="row",col=hmcol,ColSideColors=csc,
main="Bovine Data Top 25: NFM",Colv=NA,cexRow=1.5,cexCol=1.5)
temp<-

F[-c(24104:24128),J

b.ramp <- colorRampPalette(brewer.pal(9,"Blues")[-c(1:3)])
dcol <- densCols(LFC,temp$F,colramp=b.ramp)
### Can make a volcano

plot using F-statistics
...
plot(LFC,temp$F,col=dcol,pch=16,cex=1,xlab="Log
Fold Change",
ylab="F Statistics",main="Volcano
Plot of Bovine Data: NFM")
### . .. or p-values.
In this case, -log10 p-values used .
plot(LFC,logp,col=dcol,pch=16,cex=1,xlab="Log
Fold Change",
ylab="-Log 10 P-values",main="Volcano
Plot of Bovine Data: NFM")

Permutation

Test

This is the function used to run the permutation test on any AffyBatch object .
It requires that a vector indicating the treatment effect be passed, the number of permutations to be run and a vector of genes. If the maximum number of permutations
is smaller than the number passed to the function, it will run the maximum number
instead.
###

Needs nfm . test.function.070308.R

nfm.perm <- function(data,trt,nperm=1000,gn.sub)
{

set. seed(123)
max. perms<- factorial(length(trt))/prod(apply(table(trt),1,factorial))
if(nperm>max.perms)
{

require(twilight)
<- trt
perm.mat<twilight.combi(x,pin=F,bin=F)
nfm .mat <- matrix(O,length(gn.sub),max.perms-1)
for(i in 1 : (max.perms-1))
X

{

nfm.mat[,i]
<- nfm.test(data=data,trt=perm.mat[i,]
cat("Iteration:"
,i, "Time:" ,date(), "\n")
}

}else{
nfm.mat <- matrix(O,length(gn.sub),nperm)

,gn.sub=gn.sub)[,1]
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for(i

in 1:nperm)

{

trt.perm
<- sample(trt,length(trt))
nfm.mat[,i]
<- nfm.test(data=data,trt=trt.perm,gn.sub=gn.sub)
11
cat("iteration:
,i, "Time : " ,date(), "\n")
}
}

return(nfm
}

.mat)

